Sagimet Biosciences Inc. – Filings and Transcripts

NASDAQ: SGMT
Share price (11/6/26): $9.85
Market cap (11/6/26): $695 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Commodore Capital LP

Balyasny Asset Management L.P.

News Filter

Investor Presentation

Material Definitive Agreement, Financial Statements or Exhibits

Announces Positive Full 52-Week Results From License Partner Ascletis’ Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC